Derendorf, Hartmut.
Hartmut Derendorf
Derendorf, Hartmut, 1953-2020
VIAF ID: 92784677 (Personal)
Permalink: http://viaf.org/viaf/92784677
Preferred Forms
- 200 _ | ‡a Derendorf ‡b Hartmut
- 100 1 _ ‡a Derendorf, Hartmut
-
-
- 100 1 _ ‡a Derendorf, Hartmut
- 100 1 _ ‡a Derendorf, Hartmut
- 100 1 _ ‡a Derendorf, Hartmut
- 100 1 _ ‡a Derendorf, Hartmut
-
-
-
-
-
- 100 1 _ ‡a Derendorf, Hartmut ‡d 1953-2020
-
-
- 100 0 _ ‡a Hartmut Derendorf
4xx's: Alternate Name Forms (13)
5xx's: Related Names (4)
- 551 _ _ ‡a Dortmund ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 551 _ _ ‡a Gainesville, Fla. ‡4 orts ‡4 https://d-nb.info/standards/elementset/gnd#placeOfDeath
- 551 _ _ ‡a Gainesville, Fla. ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a University of Florida ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Applied pharmacometrics | |
Arzneimittelkunde | |
Biopharmazeutische Untersuchungen an schwachen Analgetika | |
Clinical pharmacokinetics and pharmacodynamics | |
Drug actions basic principles and therapeutic aspects | |
Farmakokinetyka : podstawy i znaczenie praktyczne | |
n93803843 | |
Patientenberatung in der Apotheke erweiterte Patientenberatung als Bestandteil der pharmazeutischen Betreuung ; mit 15 Tabellen | |
Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers | |
Pharmacometrics in dose finding or dose optimization of anti-retroviral and anti-tubercular drugs | |
Pharmakokinetik Einführung in die Theorie und Relevanz für die Arzneimitteltherapie ; 29 Tabellen | |
Pharmakokinetik kompakt : Grundlagen und Praxisrelevanz | |
pharmazeutisch-technische Assistent | |
Polymethoxylated Flavones and Other Phenolic Derivates from Citrus in Their Inhibitory Effects on P-Glycoprotein-Mediated Transport of Talinolol in Caco-2 Cells | |
POP PatientenOrientierte Pharmazie Klinisches Medikationsmanagement - 17 Fälle | |
Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children | |
Population pharmacodynamic model of bronchodilator response to inhaled albuterol in children and adults with asthma | |
Population Pharmacokinetic Model of Human Insulin Following Different Routes of Administration | |
Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed-effects analysis | |
Population pharmacokinetics of digoxin in Egyptian pediatric patients: impact of one data point utilization | |
Population pharmacokinetics of eniporide and its metabolite in healthy subjects and patients with acute myocardial infarction | |
Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury | |
Potential of pharmacokinetic profiling for detecting herbal interactions with drugs | |
Potentiation of ceftazidime by avibactam against β-lactam-resistant Pseudomonas aeruginosa in an in vitro infection model | |
Predicting pediatric age-matched weight and body mass index | |
Professor Yuichi Sugiyama: A Brilliant, Creative, Amicable, Charming, and Humorous Pharmaceutical Scientist. | |
Proposal for a standardised identification of the mono-exponential terminal phase for orally administered drugs. | |
Protein binding: do we ever learn? | |
Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis | |
Quantitation of the impact of CYP3A5 A6986G polymorphism on quetiapine pharmacokinetics by simulation of target attainment. | |
Quantitative determination of armodafinil in human plasma by liquid chromatography-electrospray mass spectrometry: Application to a clinical study | |
Quantitative Estimation of Plasma Free Drug Fraction in Patients With Varying Degrees of Hepatic Impairment: A Methodological Evaluation. | |
Race-Specific Pharmacodynamic Model of Propofol-Induced Loss of Consciousness | |
Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy | |
Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments | |
Resistance and the management of complicated skin and skin structure infections: the role of ceftobiprole | |
Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in Mice | |
Risk-benefit value of inhaled glucocorticoids: a pharmacokinetic/pharmacodynamic perspective | |
Roger W. Jelliffe, M.D. (1929-2020) | |
Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline. | |
Role of drug absorption in the pharmacokinetics of therapeutic interventions for stroke | |
Role of pharmacokinetics in establishing bioequivalence for orally inhaled drug products: workshop summary report. | |
Science and Evidence-based Review and Approval of COVID-19 Vaccines: A Statement of Support for the U.S. FDA | |
A selective LC/RIA for dexamethasone and its prodrug dexamethasone-21-isonicotinate in biological fluids | |
Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily | |
Simulation-based sodium thiosulfate dosing strategies for the treatment of calciphylaxis | |
Simultaneous Characterization of Intravenous and Oral Pharmacokinetics of Lychnopholide in Rats by Transit Compartment Model | |
Simultaneous quantification of cannabinoids tetrahydrocannabinol, cannabidiol and CB1 receptor antagonist in rat plasma: An application to characterize pharmacokinetics after passive cannabis smoke inhalation and co-administration of rimonabant | |
Simultaneous Retrodialysis by Calibrator for Rapid In Vivo Recovery Determination in Target Site Microdialysis | |
Single- and multiple-dose pharmacokinetics of oral creatine. | |
Skin and soft tissue concentrations of tedizolid (formerly torezolid), a novel oxazolidinone, following a single oral dose in healthy volunteers | |
Soft-tissue penetration of ceftobiprole in healthy volunteers determined by in vivo microdialysis | |
Suppression of ciprofloxacin-induced resistant Pseudomonas aeruginosa in a dynamic kill curve system | |
Systemic availability and pharmacokinetics of thymol in humans. | |
Theory and Application of Microdialysis in Pharmacokinetic Studies | |
Thromboelastographic and pharmacokinetic profiles of micro- and macro-emulsions of propofol in swine | |
Tissue concentrations: do we ever learn? | |
Tissue Distribution of a Therapeutic Monoclonal Antibody Determined by Large Pore Microdialysis | |
Tissue penetration of cefpodoxime into the skeletal muscle and lung in rats | |
Tobacco smoke exposure induces nicotine dependence in rats | |
Toxicological and Pharmacokinetic Evaluation of Concomitant Intake of Grapefruit Juice and Simvastatin in Rats after Repeated Treatment over 28 Days | |
Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations | |
Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization | |
Variability in response to cardiovascular drugs | |
Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. | |
What is the best marker for inhaled corticosteroid safety? | |
When is protein binding important? |